3 Buys Suffering From the Health-Care Hangover

Published July 23, 2010

3 Buys Suffering From the Health-Care Hangover
Three ideas in value territory for a much-needed sector.
Read more on The Motley Fool

Strong Quarter for Alexion
The company earned 39 cents per share in the reported quarter as against 26 cents in the year-ago quarter. The Zacks Consensus Estimate for the second quarter of 2010 was 30 cents per share.
Read more on Zacks.com via Yahoo! Finance

NicOx Plunges 21% on FDA Rejection of Arthritis Drug
Adhering to the advice of a May panel of rheumatologists and drug safety experts, the FDA has refused to approve NicOx SA’s experimental osteoarthritis drug naproxcinod until more studies are completed, which sent the French drugmaker’s stock into a tailspin Thursday.
Read more on BioWorld